Crowdonomics
GENOMIC EXPRESSION

Reg CF · Convertible Note · Oct 2024

ClosedReached targetReg CFConvertible Note
via StartEngine · last checked Oct 4, 2026View campaign
Raised
$125K / $1.2M max
10% of ceiling · target hit day 17
Investors
76
$1.7K avg
Valuation cap
$50M
cap, not an agreed valuation

Raised over time

Cumulative raisedInvestors
$126K$63K$0
75380
Oct 1, 2024 · openedFeb 7, 2025 · last reading
Target ($15K) hit — Oct 18, 2024, day 17Deadline Oct 28, 2024

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via StartEngine, last checked Oct 4, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$1.4M
$129K
FY2022
$608K
−$127K
FY2023
RevenueNet income
Metric
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$1,368,461
$608,380
Cost of goods sold
$325,973
$236,708
Gross margin
76%
61%
Net income
$128,549
-$127,064
Taxes paid
$0
$0
Balance sheet
Cash
$234,379
$66,375
Accounts receivable
$330,958
$349,138
Total assets
$1,019,887
$1,076,741
Short-term debt
$89,738
$201,198
Long-term debt
$277,920
$337,217
Total liabilities
$367,658
$538,415
Other
Headcount
—
5

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

2 amendments
  1. Dec 6, 2024
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  2. Oct 16, 2024
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Valuation cap$50M
Conversion discount20% (30% early bird)
Interest rate8%

Perks

Invest $1,000+ and receive a 30% discount on your 1st oneRNA test for breast or ovarian cancer$1K+

Offering details

Target$15,000
Max$1,235,000
Min investment$250
OpenedOct 1, 2024
DeadlineOct 28, 2024
ClosedFeb 6, 2025
Days active128

Links & provenance

Source: SEC EDGAR
0001665160-24-001361
Last synced Aug 18, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.